ARVN Arvinas Inc.

BEARISH Impact: 7/10 PRESS-RELEASE
Horizon days Filed May 5, 2026 Processed 1mo ago Wire GlobeNewswire
Press release: earnings
Latest settled — T+20d
ARVN ▼ -24.60% at T+20d
SHORT call ✓ call won +24.60% · α vs SPY +29.55% · entry $10.61 → $8.00
Next anchor: T+60d in 7w
Currently $7.58 · +28.56% from $10.61 entry (call sign-flipped)
Entry anchored
May 5, 2026
via day open
T+1d
-3.30%
call +3.30% · α +4.68%
$10.26
settled 5w ago
T+5d
-9.80%
call +9.80% · α +11.79%
$9.57
settled 5w ago
T+20d
-24.60%
call +24.60% · α +29.55%
$8.00
settled 10d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Arvinas reported Q4 2025 EPS of -$1.10, a 14.7% miss vs consensus of -$0.96, with revenue of $17.2M (in line). The miss is significant given the company's pre-commercial stage and high cash burn, though the press release focuses on an upcoming Q1 2026 webcast rather than providing detailed financials or guidance.

Actionable Insight

The EPS miss and lack of guidance raise concerns about cash runway and clinical progress. Watch the May 12 webcast for Q1 2026 results and any pipeline updates, particularly on ARV-102 and ARV-806. The stock has been highly volatile with negative T+20 returns on prior reports.

Key Facts

  • EPS of -$1.10 missed consensus of -$0.96 by 14.7%
  • Revenue of $17.2M was in line with consensus
  • No guidance or financial details provided in the press release
  • Management to review Q1 2026 results on May 12, 2026 webcast
  • Historical performance shows 13% win rate at T+20 on prior reports

Financial Impact

EPS miss of $0.14 per share vs consensus; no revenue surprise

eps

Risk Factors

  • Cash burn rate may accelerate without near-term revenue catalysts
  • Clinical trial failures or delays could further pressure the stock
  • High short interest and low win rate on prior calls suggest persistent negative momentum

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
62% bullish (26 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3287471
16 reports for ARVN
Performance horizon
88% Hit rate 7 of 8 directional calls best @ T+60▲ +28.62%Feb 23, 2026
Filters
Rows
Reports for ARVN — sortable, filterable
Type Now
Jun 2, 2026
10d ago
8-K
BEARISH ★ 6/10
$7.70 $7.74▼ −0.52%▼ −0.12%$7.58 (+1.56%)
May 12, 2026
4w ago
8-K
MIXED ★ 6/10
$9.57 $9.87▲ +3.13%▲ +2.56%$7.58 (−20.79%)
May 12, 2026
4w ago
8-K
BULLISH ★ 7/10
$9.57 $9.87▲ +3.13%▲ +2.56%$7.58 (−20.79%)
May 12, 2026
4w ago
Press Release
BEARISH ★ 8/10
$9.57 $9.87▼ −3.13%▼ −2.56%$7.58 (+20.79%)
May 8, 2026
5w ago
144
NEUTRAL ★ 2/10
$9.66 $9.57▼ −0.93%▼ −0.80%$7.58 (−21.53%)
May 8, 2026
5w ago
144
NEUTRAL ★ 2/10
$9.66 $9.57▼ −0.93%▼ −0.80%$7.58 (−21.53%)
May 5, 2026
5w ago
Press Release
BEARISH ★ 7/10
$10.61 $10.26▲ +3.30%▲ +4.68%$7.58 (+28.56%)
May 1, 2026
6w ago
8-K
BULLISH ★ 8/10
$10.51 $10.78▲ +2.57%▲ +2.91%$7.58 (−27.88%)
May 1, 2026
6w ago
Press Release
BULLISH ★ 8/10
$10.51 $10.78▲ +2.57%▲ +2.91%$7.58 (−27.88%)
Apr 29, 2026
6w ago
DEFA14A
NEUTRAL ★ 3/10
$9.82 $9.90▲ +0.81%▼ −0.21%$7.58 (−22.81%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (48h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access